|
MRPS23 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.36120000000662E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.40149999999328E-05 |
| Normal-vs-Stage2 |
6.923600E-02 |
| Normal-vs-Stage3 |
1.501930E-03 |
| Normal-vs-Stage4 |
5.679400E-01 |
| Stage1-vs-Stage2 |
5.143400E-01 |
| Stage1-vs-Stage3 |
9.533200E-01 |
| Stage1-vs-Stage4 |
1.038450E-02 |
| Stage2-vs-Stage3 |
5.790400E-01 |
| Stage2-vs-Stage4 |
2.329400E-01 |
| Stage3-vs-Stage4 |
4.062300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.2523000000072E-05 |
| Normal-vs-AfricanAmerican |
3.388000E-02 |
| Normal-vs-Asian |
8.112600E-01 |
| Caucasian-vs-AfricanAmerican |
8.540600E-01 |
| Caucasian-vs-Asian |
4.512800E-01 |
| AfricanAmerican-vs-Asian |
4.817800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.809300E-04 |
| Normal-vs-Female |
5.020100E-04 |
| Male-vs-Female |
7.962200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.698900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.245290E-04 |
| Normal-vs-Age(61-80Yrs) |
7.118800E-03 |
| Normal-vs-Age(81-100Yrs) |
7.587700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.601400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.141950E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.988600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.463200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.614600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.015000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.924900E-03 |
| Normal-vs-Grade 2 |
1.09800000003268E-06 |
| Normal-vs-Grade 3 |
3.597000E-03 |
| Normal-vs-Grade 4 |
6.081600E-01 |
| Grade 1-vs-Grade 2 |
8.347400E-01 |
| Grade 1-vs-Grade 3 |
5.003200E-01 |
| Grade 1-vs-Grade 4 |
1.000600E-01 |
| Grade 2-vs-Grade 3 |
1.237190E-01 |
| Grade 2-vs-Grade 4 |
2.559600E-02 |
| Grade 3-vs-Grade 4 |
1.957170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.971900E-04 |
| Normal-vs-ccB subtype |
1.180350E-03 |
| ccA subtype-vs-ccB subtype |
5.594000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.958800E-04 |
| Normal-vs-N1 |
2.663000E-01 |
| N0-vs-N1 |
1.100390E-02 |
|
|
